Wrightia arborea
Wrightia arborea · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Wrightia arborea is a medicinal plant that has garnered significant scientific interest due to its diverse therapeutic potential. Recent investigations have focused on the biological activities of various preparations, including leaf extracts and the methanolic extract of Wrightia arborea (MEWA). Researchers specifically utilize chloroform extract (WAC) to explore the plant's efficacy against complex physiological challenges. Key areas of study include the plant's ability to mitigate DNA damage and its impact on gastrointestinal disorders. Furthermore, its pharmacological properties are being evaluated through its effects on K562 cells to better understand its medicinal value.
- Synonyms
- Beaumontia Wallichii · Chonemorpha Vestita · 10 more
- Common names
- Not available
- Family
- Apocynaceae
- Distribution
- Australasia
- Plant Parts
- Leaf
Classification
Common Names
Wrightia arborea is a fascinating plant that is recognized by a diverse array of regional names across different cultures. In various local dialects, it is frequently referred to as Aatkuri or Ayyappala. Moving through different linguistic landscapes, one might also encounter it known as Benki gida or the closely related Benki-gida. Additionally, the plant is identified as Bilikada in certain traditional contexts. These varying common names highlight the widespread presence and cultural importance of this species.
Sources: Catalogue of Life (COL)
Synonyms
Wrightia arborea is a botanical subject characterized by a complex web of taxonomic synonyms that often lead to scientific discussion. Within various botanical records, this species has been closely associated with names such as Beaumontia wallichii and Chonemorpha vestita. Further nomenclatural overlaps exist, as it has also been identified under the synonyms Echites vestitus and Hunteria eugeniifolia. Additionally, the plant is sometimes linked to the name Nerium coraea in historical or specialized contexts. Navigating these diverse linguistic connections is essential for accurately identifying the plant across different scientific literatures.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Wrightia arborea belongs to the vast kingdom Plantae, representing a diverse group of multicellular organisms. Within this kingdom, the species is classified under the class Equisetopsida. It further falls into the order Gentianales, a group characterized by specific botanical traits. Moving down the taxonomic hierarchy, it is a member of the family Apocynaceae. Finally, this plant is nested within the specific genus Wrightia.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Gentianales |
| Family | Apocynaceae |
| Genus | Wrightia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Wrightia arborea displays a broad and diverse geographic distribution that spans across multiple Asian regions. In temperate climates, the species is well-established within the central and southeastern provinces of China. Moving into tropical zones, the plant thrives across the Indian Subcontinent, specifically within the lush landscapes of Assam and Bangladesh. Its presence also extends into the unique ecological niche of the East Himalaya. This wide range highlights the plant's ability to adapt to both temperate and tropical environments throughout Asia.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Wrightia arborea grows in a tree form and is a naturally self-supporting species. This plant typically reaches a maximum height of 14 meters as it matures. Its sturdy structure allows it to stand prominently within its natural environment.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Conditions
Wrightia arborea demonstrates significant analgesic properties by treating acetic acid-induced writhing, which represents chemically induced pain. The plant also exhibits potent anti-inflammatory effects, as evidenced by its ability to treat both the formalin-induced and carrageenan-induced hind paw edema models. Furthermore, leaf extracts of this plant have been shown to selectively induce DNA damage in specific cancer cell lines. This process is further characterized by the plant's capacity to cause G2 abrogation, leading to mitochondrial apoptosis. These combined medicinal activities highlight the plant's potential as a therapeutic agent for pain, inflammation, and cancer.
Preparations
Wrightia arborea is prepared as leaf extract and various leaf extracts to evaluate its antiproliferative and apoptotic potential against different cancer cell lines. Specifically, Wrightia arborea is prepared as chloroform extract (WAC), which has been shown to selectively kill K562 leukemic cells through DNA damage and G2 abrogation. Furthermore, Wrightia arborea is prepared as methanolic extract of Wrightia arborea (MEWA) for the study of its pharmacological properties. Research indicates that MEWA possesses significant anti-nociceptive and anti-inflammatory activities in animal models. These diverse preparation methods highlight the plant's versatile utility in both oncological and analgesic research.
Parts used
Wrightia arborea serves as a significant subject in pharmacological research due to the potent bioactive constituents found within its foliage. Specifically, the plant's leaf has been identified as a primary source of medicinal compounds capable of inducing selective cell death. Recent studies demonstrate that extracts from these leaves can trigger mitochondrial apoptosis and DNA damage in specific leukemic cancer cell lines. By targeting G2 phase abrogation, the leaf extract offers a specialized approach to antiproliferative therapy. Consequently, the leaf of this traditional Ayurvedic plant represents a valuable bioresource for developing future chemopreventive therapeutics.